Top

Published in:

01-04-2017 | Short Communication

Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems

Author: Tarek Hassanein

Published in: Metabolic Brain Disease | Issue 2/2017

Abstract

Hepatic Encephalopathy is a devastating complication of End-Stage Liver Disease. In its severe grades it requires extra intervention beyond the standard medical approaches. In this article were view the role of liver support systems in managing hepatic encephalopthy.

Agrawal A, Sharma BC, Sharma P, Sarin SK (2012) Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol 107(7):1043–1050CrossRefPubMed

Amodio P, Bemeur C, Butterworth R, et al. (2013) The nutritional management of hepatic encephalopathy in patients with cirrhosis: international society for hepatic encephalopathy and nitrogen metabolism consensus. Hepatology 58(1):325–336CrossRefPubMed

Bajaj JS, Cordoba J, Mullen KD, et al. (2011) Review article: the design of clinical trials in hepatic encephalopathy: an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 33(7):739–747CrossRefPubMedPubMedCentral

Bañares R, Catalina M (2011) “Extracorporeal artificial liver support systems”. Clinical gastroenterology: Chronic Liver Failure. Ed. P Gines. Springer Science + Business Media, LLC. 501–519. Print

Banares R, Nevens F, Larsen FS, et al. (2013) Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the relief trial. Hepatology 57(3):1153–1162CrossRefPubMed

Buckner CD, Clift RA, Volwiler W, Donohue DM, Burnell JM, Saunders FC, Thomas ED (1973) Plasma exchange in patients with fulminant hepatic failure. Arch Intern Med 132:487–492

Cree IC, Straus E, Berger S, Voges P, Scotti P, Atkins P (1973) Plasma exchange in treatment of profound hepatic coma. N Y State J Med 73:569–576

Demeulenaere L, Barbier F, Vermeire P (1969) Plasmapheresis in hepatic coma. Lancet 1:152–153

Dethloff T, Tofteng F, Frederiksen HJ, et al. (2008) Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study. World J Gastroenterol 14(13):2065–2071CrossRefPubMedPubMedCentral

Evenepoel P, Laleman W, Wilmer A, et al. (2006) Prometheus versus molecular adsorbents recirculating system: comparison of efficacy in two different liver detoxification devices. Artif Organs 30(4):276–284CrossRefPubMed

Ferenci P, Lockwood A, Mullen K, et al. (2002) Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998. Hepatology 35:716–721CrossRefPubMed

Freeman JG, Matthewson K, Record CO (1986) Plasmapheresis in acute liver failure. Int J Artif Organs 9:433–438

Hassanein TI, Tofteng F, Brown RS Jr, et al. (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46(6):1853–1862CrossRefPubMed

Hassanein TI, Schade RR, Hepburn IS (2011) Acute-on-chronic liver failure: extracorporeal liver assist devices. Curr Opin Crit Care 17:195–203

Kondrup J, Almdal T, Vilstrup H, Tygstrup N (1992) High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs 15:669–676

Kribben A, Gerken G, Haag S, Herget-Rosenthal S, et al. (2012) Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 142(4):782–789 e.3CrossRefPubMed

Larsen FS, Hansen BA, Ejlersen E, Secher NH, Clemmesen JO, Tygstrup N, Knudsen GM (1996) Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during highvolume plasmapheresis in fulminant hepatic failure. Eur J Gastroenterol Hepatol 8:261–265

Laleman W, Wilmer A, Evenepoel P, et al. (2006) Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 10(4):R108CrossRefPubMedPubMedCentral

Lepore MJ, Stutman LJ, Bonanno CA, Conklin EF, Robilotti JG,McKenna PJ (1972) Plasmapheresis with plasma exchange in hepatic coma. II. Fulminant viral hepatitis as a systemic disease. Arch Intern Med 129:900–907

Merli M, Lucidi C, Pentassuglio I, et al. (2013) Increased risk of cognitive impairment in cirrhotic patients with bacterial infections. J Hepatol 59(2):243–250CrossRefPubMed

Ortiz M, Jacas C, Cordoba J (2005) Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 42(suppl 1):S45–S53CrossRefPubMed

Pugliese F, Novelli G, Poli L, et al. (2008) Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients. Transplant Proc 40(6):1925–1928CrossRefPubMed

Rahimi RS, Elliott AC, Rockey DC (2013) Altered mental status in cirrhosis: etiologies and outcomes. J Investig Med 61(4):695–700CrossRefPubMed

Sekido H, Matsuo K, Takeda K, Ueda M, Morioka D, Kubota T, Tanaka K, Endo I, Togo S, Shimada H (2004) Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc 36:2355–2356

Splendiani G, Tancredi M, Daniele M, Giammaria U (1990) Treatment of acute liver failure with hemodetoxification techniques. Int J Artif Organs 13:370–374

Stenbog P, Busk T, Larsen FS (2013) Efficacy of liver assisting in patients with hepatic encephalopathy with special focus on plasma exchange. Metab Brain Dis 28(2):333–335CrossRefPubMed

Stepanova M, Mishra A, Venkatesan C, Younossi ZM (2012) In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol 10(9):1034–1041 e1CrossRefPubMed

Stewart CA, Malinchoc M, Kim WR, Kamath PS (2007) Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 13(20):1366–1371CrossRefPubMed

Yoshiba M, Sekiyama K, Iwamura Y, Sugata F (1993) Development of reliable artificial liver support (ALS)–plasma exchange in combination with hemodiafiltration using high-performance membranes. Dig Dis Sci 38:469–476

Title: Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems
Author: Tarek Hassanein
Publication date: 01-04-2017
Publisher: Springer US
Published in: Metabolic Brain Disease / Issue 2/2017
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-016-9911-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis

Effects of Jiaotaiwan on depressive-like behavior in mice after lipopolysaccharide administration

A novel frameshift mutation in the sterol 27-hydroxylase gene in an Egyptian family with cerebrotendinous xanthomatosis without cataract

Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine

Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy

Omega-3 fatty acids and mood stabilizers alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration